Middle East gains breast cancer blood test
This article was originally published in Clinica
US company Power3 Medical Products has launched its breast cancer diagnostic blood test BC-SeraPro in 12 Middle Eastern countries. The Texas-based company (The Woodlands) expects the test to be performed in conjunction with mammography, and believes that it will help reduce the number of patients subjected to erroneous results from mammograms - which is allegedly 50% of women screened in the US.
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.
Following Aspen’s admission last year that it was party to an illegal, anti-competitive agreement on fludrocortisone, Tiofarma has now also conceded to the UK’s Competition and Markets Authority that it took part in the deal.